Chikungunya virus can now be transmitted across most of Europe

Data suggest that the climate crisis and invasive mosquitoes could spread this disease in 29 countries, including Spain Chikungunya virus can now be transmitted across most of EuropeData suggest that the climate crisis and invasive mosquitoes could spread this disease in 29 countries, including Spain Data suggest that the climate crisis and invasive mosquitoes could […]

Glycoscience selected to participate in B-Venture 2026

Glycoscience has been selected among more than 700 applications to be part of the 25 finalist startups participating in the 11th edition of B-Venture We are pleased to announce that Glycoscience has been selected among more than 700 applications to be part of the 25 finalist startups participating in the 11th edition of B-Venture, one […]

Glyco-Protec® has officially received regulatory approval for commercialization in Italy

We are excited to share an important milestone: Glyco-Protec® has officially received regulatory approval for commercialization in Italy, widely considered the most demanding market in Europe for mosquito repellents. This achievement is the result of a long and rigorous process, during which our documentation was thoroughly reviewed with no issues. Glyco-Protec® is now approved as […]

Glycoscience’s participation in the CPHI Frankfurt 2025 international trade show has been a resounding success for the company

During this key international event for the pharmaceutical industry, our team presented the latest innovations in controlled-release technologies applied to natural products, with a special focus on our insect repellents with certified efficacy exceeding 12 hours. The presentation attracted strong interest from international distributors and potential strategic partners, resulting in a significant number of high-value […]

Glycoscience will be at CPHI Frankfurt 2025

We’re excited to announce that Glycoscience will be exhibiting at CPHI Frankfurt 2025—the leading international event for professionals in the pharmaceutical industry. We’ll be showcasing our latest innovations and biotech solutions. 📅 October 28–30, 2025📍 Booth 4S68 – Messe Frankfurt, Germany It’s a great opportunity to explore how our biotechnology is helping build a healthier, more sustainable, […]

Our innovative insect repellent, also suitable for children, is now available in Spain under the brand name FILVIT® by Laboratorios ERN.

Thanks to a licensing agreement with Laboratorios ERN, a leading pharmaceutical company with a strong track record and endorsement from health professionals, our innovative insect repellent developed with Glycoscience’s proprietary technology is now available in the Spanish market under the well-known brand FILVIT®. FILVIT® repellent, formulated with GLYCO-PROTEC controlled release technology, offers long-lasting protection of […]

Tick-Borne Encephalitis

Climate change has led to an increase in the tick population, thereby raising the risk of diseases they can transmit. The European Vaccination Information Portal warns of the dangers of Tick-Borne Encephalitis (TBE). This viral infectious disease affects the human central nervous system and is prevalent in many parts of Europe and Asia. The virus […]